Loss of SMAD4 staining in pre-operative cell blocks is associated with distant metastases following pancreaticoduodenectomy with venous resection for pancreatic cancer.

作者: Brian A. Boone , Shirin Sabbaghian , Mazen Zenati , J. Wallis Marsh , A. James Moser

DOI: 10.1002/JSO.23606

关键词:

摘要: Background and Objectives Venous resection of locally advanced pancreatic cancer is associated with increased morbidity mortality; therefore identification patients most likely to benefit from this aggressive surgical approach an important goal. Loss SMAD4 staining on resected specimens has been outcomes. Few studies have evaluated the prognostic significance pre-operative cell blocks, which would be useful in clinical decision making for disease. Methods Clinical data were retrospectively all undergoing pancreaticoduodenectomy venous resection. Immunohistochemical was performed blocks subsequent post-operative resections. Results One hundred seventeen underwent Sixty had sufficient available staining. loss observed 70% resections earlier time metastatic disease. Pre-operative correlated well six times higher likelihood developing metastases. Conclusion In pilot study, preoperative showed a strong correlation postoperative predicted metastases cancer. Preoperative status may considered as one several factors when selecting en bloc J. Surg. Oncol. 2014; 110:171–175. © 2014 Wiley Periodicals, Inc.

参考文章(25)
Robb E. Wilentz, Gloria H. Su, Jia Le Dai, Andrew B. Sparks, Pedram Argani, Taylor A. Sohn, Charles J. Yeo, Scott E. Kern, Ralph H. Hruban, Immunohistochemical labeling for Dpc4 mirrors genetic status in pancreatic adenocarcinomas: A new marker of DPC4 inactivation American Journal of Pathology. ,vol. 156, pp. 37- 43 ,(2000) , 10.1016/S0002-9440(10)64703-7
Charles A. Staley, James C. Cusack, Chusilp Charnsangavej, Karen R. Cleary, Adel K. El-Naggar, Claudia J. Fenoglio, Jeffrey E. Lee, Douglas B. Evans, George M. Fuhrman, Steven D. Leach, Rationale for En Bloc Vein Resection in the Treatment of Pancreatic Adenocarcinoma Adherent to the Superior Mesenteric-Portal Vein Confluence Annals of Surgery. ,vol. 223, pp. 154- 162 ,(1996) , 10.1097/00000658-199602000-00007
H RIEDIGER, F MAKOWIEC, E FISCHER, U ADAM, U HOPT, Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection Journal of Gastrointestinal Surgery. ,vol. 10, pp. 1106- 1115 ,(2006) , 10.1016/J.GASSUR.2006.04.002
T SOHN, C YEO, J CAMERON, L KONIARIS, S KAUSHAL, R ABRAMS, P SAUTER, J COLEMAN, R HRUBAN, K LILLEMOE, Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. Journal of Gastrointestinal Surgery. ,vol. 4, pp. 567- 579 ,(2000) , 10.1016/S1091-255X(00)80105-5
Sang Hyun Shin, Song Cheol Kim, Seung-Mo Hong, Young Hoon Kim, Ki-Byung Song, Kwang-Min Park, Young-Joo Lee, Genetic Alterations of K-ras, p53, c-erbB-2, and DPC4 in Pancreatic Ductal Adenocarcinoma and Their Correlation With Patient Survival Pancreas. ,vol. 42, pp. 216- 222 ,(2013) , 10.1097/MPA.0B013E31825B6AB0
Anthony W. Castleberry, Rebekah R. White, Sebastian G. De La Fuente, Bryan M. Clary, Dan G. Blazer, Richard L. McCann, Theodore N. Pappas, Douglas S. Tyler, John E. Scarborough, The Impact of Vascular Resection on Early Postoperative Outcomes after Pancreaticoduodenectomy: An Analysis of the American College of Surgeons National Surgical Quality Improvement Program Database Annals of Surgical Oncology. ,vol. 19, pp. 4068- 4077 ,(2012) , 10.1245/S10434-012-2585-Y
Sung-Sik Han, Sang-Jae Park, Seong Hoon Kim, Seong Yeon Cho, Young-Kyu Kim, Tae Hyun Kim, Soon-ae Lee, Sang Myung Woo, Woo Jin Lee, Eun Kyung Hong, Clinical significance of portal-superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head cancer. Pancreas. ,vol. 41, pp. 102- 106 ,(2012) , 10.1097/MPA.0B013E318221C595
Jordan M. Winter, Laura H. Tang, David S. Klimstra, Weiguo Liu, Irena Linkov, Murray F. Brennan, Michael I. DʼAngelica, Ronald P. DeMatteo, Yuman Fong, William R. Jarnagin, Eileen M. OʼReilly, Peter J. Allen, Failure Patterns in Resected Pancreas Adenocarcinoma: Lack of Predicted Benefit to SMAD4 Expression Annals of Surgery. ,vol. 258, pp. 331- 335 ,(2013) , 10.1097/SLA.0B013E31827FE9CE
Mark P. Callery, Kenneth J. Chang, Elliot K. Fishman, Mark S. Talamonti, L. William Traverso, David C. Linehan, Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement Annals of Surgical Oncology. ,vol. 16, pp. 1727- 1733 ,(2009) , 10.1245/S10434-009-0408-6
Niki A. Ottenhof, Folkert H. M. Morsink, Fiebo ten Kate, Cornelis J. F. van Noorden, G. Johan A. Offerhaus, Multivariate analysis of immunohistochemical evaluation of protein expression in pancreatic ductal adenocarcinoma reveals prognostic significance for persistent Smad4 expression only. Cellular Oncology. ,vol. 35, pp. 119- 126 ,(2012) , 10.1007/S13402-012-0072-X